NEW YORK, Jan. 9, 2015 /PRNewswire/ -- Levi & Korsinsky
announces that the class period for a case commenced on behalf of
Aeterna Zentaris Inc. ("Aeterna Zentaris" or the "Company")
(Nasdaq: AEZS) shareholders has expanded to include shareholders
who purchased shares between April 2,
2012 and November 6, 2014.
For more information, click here:
http://zlk.9nl.com/aeterna-zentaris.
The complaint alleges that Aeterna Zentaris misstated information
about its New Drug Application ("NDA") with the FDA for the drug
MACRILEN. On October 18, 2012, the
Company announced Phase III clinical trial results for MACRILEN,
noting that the results "confirm [the drug's] potential as possibly
the first approved oral diagnostic test for" ADHD. These trials
were conducted pursuant to a Special Protocol Assessment that was
agreed upon with the FDA.
On November 6, 2014, however, it
was revealed that the FDA would not approve the NDA in its present
form, noting that the "trial did not meet its stated primary
efficacy objective as agreed to in the Special Protocol Assessment
agreement letter between the Company and the FDA."
If you suffered a loss in Aeterna Zentaris you have until
January 12, 2015 to request that the
Court appoint you as lead plaintiff. Your ability to share in any
recovery doesn't require that you serve as a lead plaintiff. To
obtain additional information, contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972, or visit http://zlk.9nl.com/aeterna-zentaris.
Levi & Korsinsky is a national firm with offices in
New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits and have helped shareholders
recover millions of dollars in losses over the years. For more
information, please feel free to contact any of the attorneys
listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY
10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com
Logo -
http://photos.prnewswire.com/prnh/20120409/MM84375LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/update--monday-deadline-levi--korsinsky-llp-notifies-investors-of-class-action-against-aeterna-zentaris-inc-and-its-board-of-directors-and-a-lead-plaintiff-deadline-of-january-12-2015----aezs-300018515.html
SOURCE Levi & Korsinsky, LLP